Kensuke Oikawa

1.5k total citations
49 papers, 1.1k citations indexed

About

Kensuke Oikawa is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Kensuke Oikawa has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 20 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Kensuke Oikawa's work include Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Kensuke Oikawa is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Kensuke Oikawa collaborates with scholars based in Japan, United States and Canada. Kensuke Oikawa's co-authors include Hiroya Kobayashi, Naoko Aoki, Yasuaki Harabuchi, Esteban Celis, Takumi Kumai, Toshihiro Nagato, Shoji Kimura, Kei Ishibashi, Takayuki Ohkuri and Akemi Kosaka and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Kensuke Oikawa

48 papers receiving 1.1k citations

Peers

Kensuke Oikawa
Jodi L. Karnell United States
Sarah Wilkinson United Kingdom
Elena Miranda United Kingdom
Jeff Grein United States
Mahdia Benkhoucha Switzerland
Kensuke Oikawa
Citations per year, relative to Kensuke Oikawa Kensuke Oikawa (= 1×) peers Е. Р. Черных

Countries citing papers authored by Kensuke Oikawa

Since Specialization
Citations

This map shows the geographic impact of Kensuke Oikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Oikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Oikawa more than expected).

Fields of papers citing papers by Kensuke Oikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Oikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Oikawa. The network helps show where Kensuke Oikawa may publish in the future.

Co-authorship network of co-authors of Kensuke Oikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Oikawa. A scholar is included among the top collaborators of Kensuke Oikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Oikawa. Kensuke Oikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagato, Toshihiro, Miki Takahara, Takayuki Ohkuri, et al.. (2024). Soluble CD27 as a predictive biomarker for intra‐tumoral CD70/CD27 interaction in nasopharyngeal carcinoma. Cancer Science. 115(4). 1073–1084. 4 indexed citations
2.
Kosaka, Akemi, Kei Ishibashi, Shunsuke Yasuda, et al.. (2022). A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. Cancer Science. 113(8). 2526–2535. 8 indexed citations
3.
Kosaka, Akemi, Kei Ishibashi, Toshihiro Nagato, et al.. (2021). CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes. The Journal of Experimental Medicine. 218(11). 44 indexed citations
4.
Kosaka, Akemi, Kenzo Ohara, Hiroshi Funakoshi, et al.. (2021). A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment. Cancer Immunology Immunotherapy. 70(8). 2301–2312. 20 indexed citations
5.
Ohara, Kenzo, Takumi Kumai, Takayuki Ohkuri, et al.. (2020). Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer. Cancer Immunology Immunotherapy. 69(6). 989–999. 19 indexed citations
6.
Kosaka, Akemi, Takumi Kumai, Kenzo Ohara, et al.. (2019). Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma. Biochemical and Biophysical Research Communications. 522(2). 408–414. 19 indexed citations
7.
Ohkuri, Takayuki, Kenzo Ohara, Takumi Kumai, et al.. (2019). PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma. Journal of Translational Medicine. 17(1). 207–207. 13 indexed citations
8.
Uehara, Jiro, Takayuki Ohkuri, Akemi Kosaka, et al.. (2017). Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb. Biochemical and Biophysical Research Communications. 490(2). 521–527. 21 indexed citations
9.
Ohkuri, Takayuki, Akemi Kosaka, Kei Ishibashi, et al.. (2017). Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site. Cancer Immunology Immunotherapy. 66(6). 705–716. 156 indexed citations
10.
Ishibashi, Kei, Takumi Kumai, Takayuki Ohkuri, et al.. (2016). Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy. OncoImmunology. 5(6). e1169356–e1169356. 28 indexed citations
11.
Oikawa, Kensuke, Gary Odero, Ning Ge, et al.. (2016). Visinin-Like Protein-3 Modulates the Interaction Between Cytochrome b 5 and NADH-Cytochrome b 5 Reductase in a Ca2+-Dependent Manner. Cell Biochemistry and Biophysics. 74(4). 449–457. 3 indexed citations
12.
Karasaki, Hidenori, Yusuke Ono, Kensuke Oikawa, et al.. (2016). Tracking the Clonal Evolution of Adenosquamous Carcinoma, a Rare Variant of Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas. 45(6). 915–918. 10 indexed citations
13.
Kumai, Takumi, Kei Ishibashi, Kensuke Oikawa, et al.. (2014). Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53. Cancer Immunology Immunotherapy. 63(5). 469–478. 19 indexed citations
14.
Einama, Takahiro, Koichiro Uchida, Masahiko Taniguchi, et al.. (2014). Successful curative resection of gallbladder cancer following S-1 chemotherapy: A case report and review of the literature. Oncology Letters. 8(6). 2443–2447. 3 indexed citations
15.
Kitada, Masahiro, Yoshinari Matsuda, Satoshi Hayashi, et al.. (2013). Esophageal schwannoma: a case report. World Journal of Surgical Oncology. 11(1). 253–253. 31 indexed citations
16.
Albensi, Benedict C., et al.. (2008). Controlled pulse delivery of electrical stimulation differentially reduces epileptiform activity in Mg2+-free-treated hippocampal slices. Brain Research. 1226. 163–172. 6 indexed citations
17.
Nagato, Toshihiro, Hiroya Kobayashi, Mitsuru Yanai, et al.. (2007). Functional Analysis of Birch Pollen Allergen Bet v 1-Specific Regulatory T Cells. The Journal of Immunology. 178(2). 1189–1198. 17 indexed citations
18.
Yanai, Mitsuru, Keisuke Sato, Naoko Aoki, et al.. (2007). The role of CCL22/macrophage-derived chemokine in allergic rhinitis. Clinical Immunology. 125(3). 291–298. 26 indexed citations
19.
Takiyama, Yumi, Naoyuki Miyokawa, Akira Sugawara, et al.. (2004). Decreased Expression of Retinoid X Receptor Isoforms in Human Thyroid Carcinomas. The Journal of Clinical Endocrinology & Metabolism. 89(11). 5851–5861. 35 indexed citations
20.
Aoki, Naoko, Kensuke Oikawa, Mitsuru Yanai, et al.. (2003). Modulation of Hepatic Granulomatous Responses by Transgene Expression of DAP12 or TREM-1-Ig Molecules. American Journal Of Pathology. 162(4). 1191–1201. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026